Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |